Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Steven M. Corsello(Cancer Prevention Institute of California), Todd R. Golub(Broad Institute), Mustafa Kocak(Broad Institute), Heidi Greulich(Broad Institute), Jordan Bryan(Broad Institute), Jesse S. Boehm(Massachusetts Institute of Technology), Colin W. Garvie(Broad Institute), Ranad Humeidi(Broad Institute), Uri Ben‐David(Tel Aviv University), Evan Lemire(Broad Institute), Ryan D. Spangler(Broad Institute), Philip Montgomery(Broad Institute), Francisca Vázquez(Broad Institute), John G. Doench(Broad Institute), Jennifer A. Roth(Broad Institute), Vickie M. Wang(Broad Institute), Matthew Meyerson(Broad Institute), Bang Wong(Broad Institute), Eric Stefan(Broad Institute), Joshua A. Bittker, Patrick J. O’Hearn(Broad Institute), Matthew G. Rees(Broad Institute), James M. McFarland(Broad Institute), Aviad Tsherniak(Broad Institute), Rohith T. Nagari(Broad Institute), Yejia Chen(Broad Institute), Nicholas Lyons(Broad Institute), Christopher C. Mader(Broad Institute), Samantha Bender(Broad Institute), Jordan Rossen(Broad Institute), Li Wang(Nantong University), Xiaoyun Wu(Broad Institute), Caitlin Harrington(Stanford Health Care), D. D. Peck(Broad Institute), Aravind Subramanian(Broad Institute), Rajiv Narayan(Broad Institute), Andrew Tang(Broad Institute), Nancy Dumont(Broad Institute)
Cited by 880
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Initial sequencing and analysis of the human genome
|Nature|2001|24.6k
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k